|
 |
LevetiracetamThis page contains recent news articles, when available, and an overview of Levetiracetam but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Generic drugmaker Mylan Inc. said Friday regulators have approved an additional tablet strength for its epilepsy drug Levetiracetam. ... Forbes Malden woman pleads innocent to Saugus drug-dealing charges - Dec 22, 2009 ...trafficking over 14 grams of Oxycontin, possession of Loraz-epam with intent to distribute and unlawful possession of Levetiracetam. ... The Daily Item of Lynn Mylan Inc secures FDA approval for generic antiepileptic Keppra 1000 mg - Dec 14, 2009 The 1000 mg strength of Levetiracetam Tablets complements Mylan's already approved and marketed strengths of 250 mg, 500 mg and 750 mg. ... Trading Markets (press release) Dr Reddy's Labs' next phase of growth from PSAI and proprietary products - Dec 22, 2009 ...ciprofloxacin (antibiotic) Montelikast (asthama and anti allergic), Sumatirptan (anti migraine) and Levetiracetam (anti epileptic). ... pharmabiz.com Mylan Receives Approval For Generic Version Of Antiepileptic Keppra® 1000 Mg - Dec 12, 2009 Levetiracetam Tablets are the generic version of UCB Pharma's antiepileptic Keppra®. This additional strength of Levetiracetam Tablets complements Mylan's ... Medical News Today (press release) Vigabatrin (Sabril®): A New Epilepsy Drug -- With Strings Attached - Dec 31, 2009 ...gabapentin (Neurontin®), lacosamide (Vimpat®), lamotrigine (Lamictal®), levetiracetam (Keppra®), oxcarbazepine (Trileptal®), pregabalin (Lyrica®), ... Medscape Antiepileptic Medications May Be Risk Factors for Premenstrual Dysphoria ... - Dec 10, 2009 Of the patients, 14 were on carbamazepine, 20 on lamotrigine, 8 on levetiracetam, and 1 on topiramate; the researchers also examined 16 normal control ... DG News Not All Drugs Are the Same After All - Dec 18, 2009 ...as Budeprion XL 300 in one generic form), the heart medicine Toprol XL (metoprolol succinate) and the antiseizure medicine Keppra (levetiracetam). ... New York Times Gear Up For The New Year!! Sign Up For Our Newsletter!! LCRD,DLLR,HGSI,NETL ... - Dec 11, 2009 Levetiracetam Tablets are the generic version of UCB Pharma's antiepileptic Keppra(R). This additional strength of Levetiracetam Tablets complements Mylan's ... TMC Net Brivaracetam使用於局部發作型癲癇的çµ?æžœä¸?一 - Dec 15, 2009 ...ä¸€é …ç ”ç©¶é¡¯ç¤ºï¼Œé€™å€‹å¯¦é©—æ€§è—¥ç‰©ï¼Œçµ?構與levetiracetam相似，å?¯ä»¥èª˜ç™¼å±€éƒ¨ç™¼ä½œç™²ç™‡ã€‚然而，由å?Œä¸€åœ˜éšŠé€²è¡Œçš„å?¦ä¸€é …ç ”ç©¶é¡¯ç¤ºï¼Œä¸»è¦?療效終點並未é?”到統計上顯著差異。 ... 臺灣新浪網 Evalúan la eficacia de un tratamiento antiepiléptico - 14 Nov 2009 A nivel mundial tenemos varias drogas nuevas como carbamazepina, lacosamida, rufinamida y levetiracetam, que nosotros hemos estado utilizado desde hace ya ... La Prensa (Argentina) Promising early results for UCB's new products - Oct 22, 2009 ...revenue declined in the first nine months of 2009 compared to the same period in 2008 as a consequence of generic competition to Keppra (levetiracetam) ... Pharmacy Europe UCB announces its latest financial results - Oct 23, 2009 Its revenue declined compared to the same period in 2008, something that UCB attributes to generic competition to Keppra (levetiracetam) in the US. ... Zenopa Mylan Reports Third Quarter Adjusted Diluted EPS of $0.32 - Oct 29, 2009 Laboratories' Depakote® ER, and Levetiracetam, Mylan's version of UCB Pharma's Keppra®, and higher volumes, partially offset by unfavorable pricing. ... Reuters Dr Reddy's seeks US marketing rights for `Lipitor' generic - Nov 7, 2009 Ramipril (Altace - King), Venlafaxine (Effexor -Wyeth), Lamotrigine (Lamictal - Glaxo Smith Kline), and Levetiracetam (Keppra - UCB). ... domain-B Two Lynn men indicted for rape, attempted rape - Nov 5, 2009 ...trafficking more than 14 grams of OxyCodone, possession of Lorazepam with intent to distribute and unlawful possession of Levetiracetam. ... The Daily Item of Lynn Forecast Insight - Epilepsy - Future market upgrade following new drug launches - Oct 26, 2009 Driven primarily by continued uptake of UCB´s market leading anticonvulsant, Keppra (levetiracetam), seven major market epilepsy revenues grew strongly at a ... PR-Inside.com (Pressemitteilung) Commercial Insight: Anticonvulsants - Non-epilepsy label expansions provide ... - Nov 3, 2009 UCB´s Keppra´s (levetiracetam) is the leading treatment for epilepsy. Despite the recent launch of two further anticonvulsants and the presence of a ... PR-Inside.com (Pressemitteilung) Tire 20 dúvidas sobre métodos para evitar a gravidez - Nov 9, 2009 Outros anticonvulsivantes não parecem reduzir a eficácia contraceptiva, incluindo gabapentina (Neurontin®), lamotrigina (Lamictal®), levetiracetam (Keppra®) ... Terra Brasil 20 dudas sobre los métodos anticonceptivos - Nov 9, 2009 Otros anticonvulsivos no parecen reducir la eficacia contraceptiva, incluyendo gabapentina, lamotrigina, levetiracetam y tiagabina. ... Terra Perú Dùng quá liá»?u, phối hợp các thuốc ức chế thần kinh: Tai biến khó lÆ°á»?ng - Nov 9, 2009 Các thuốc TTPL (terfurin, thioridazin, levomepromazin), thuốc chống Ä‘á»™ng kinh (valpromid, phenytoin, levetiracetam, lorazepam, chonazepam), thuốc an thần ... Báo Hoà Bình Rapport intermédiaire - Premiers résultats prometteurs pour les nouveaux ... - Oct 21, 2009 ...premiers mois de 2009 est en recul par rapport à la même période de 2008 en raison de la concurrence des génériques de Keppra® (levetiracetam) aux USA. ... Euronext (persbericht) Tussentijds rapport - Veelbelovende eerste resultaten voor nieuwe producten ... - Oct 21, 2009 ...van 2009 in vergelijking met dezelfde periode in 2008 als gevolg van de generieke concurrentie met Keppra® (levetiracetam) in de Verenigde Staten. ... Analist.be (persbericht) Side effects of levetiracetam - Dec 4, 2008 Very few people stop taking levetiracetam because of side effects.[2] People who take levetiracetam are more than twice as likely to feel dizzy as people ... guardian.co.uk Changes in plasma levetiracetam concentrations in pregnant women and ... - May 15, 2007 Tomson T et al. (2007) Pharmacokinetics of levetiracetam during pregnancy, delivery, in the neonatal period, and lactation. Epilepsia 48: 1111–1116 PubMed ... Nature.com Keppra promising for newly diagnosed epilepsy - Feb 6, 2007 Rates of freedom from seizures with levetiracetam were comparable to those ... At present, levetiracetam is used as add-on therapy for partial seizures, ... Reuters Randomized trial supports use of levetiracetam adjunctive therapy to... - Jul 7, 2006 Glauser TA et al. (2006) Double-blind placebo-controlled trial of adjunctive levetiracetam in pediatric partial seizures. Neurology 66: 1654–1660 PubMed ... Nature.com Levetiracetam (Keppra): Dosage, Side Effects, and Interactions - Oct 29, 2007 Levetiracetam (Keppra) may be used to help control partial seizures in adults. It is usually used with, not instead of, other antiepileptic medicines ... WebMD Antiepilepsy Drug Levetiracetam (Keppra) Reduces Seizures in Brain … - Apr 13, 2005 By Ed Susman. MIAMI, FL -- April 13, 2005 -- Treatment with the anticonvulsant levetiracetam (Keppra) can prevent seizures among patients with malignant ... DG News … Adverse Events Resulting From Levetiracetam Treatment Occur in … - Dec 7, 2008 By Adi Ferrara. SEATTLE, Wash -- December 7, 2008 -- Children treated for epilepsy with levetiracetam may develop psychiatric adverse events as a result of ... DG News UCB settles Keppra patent litigation in the US - Oct 5, 2007 Under the settlement agreement, Mylan will be able to sell its generic levetiracetam tablets from Nov 1, 2008, ahead of the anticipated expiry of UCB's ... Forbes Keppra(R) (levetiracetam) As Adjunctive Treatment In Idiopathic … - Dec 6, 2005 According to new data, presented at a UCB sponsored Scientific Exhibit at the 59th Annual Meeting of the American Epilepsy Society in Washington, DC, US, ... Medical News Today - Medical News Today (press release) … Study Shows Antiepileptic Drug Levetiracetam Reduces Frequency of ... - Apr 14, 2005 ..."Our findings suggest that levetiracetam can be an effective and well-tolerated agent for ... Levetiracetam is currently approved by the US Food and Drug ... $4.95 - PR Newswire - ECNext Levetiracetam (Systemic).(Drug overview) - Aug 1, 2006 Levetiracetam ( lev-a-tear-AS-e-tam)is used to help control some types of seizures in the treatment of epilepsy. This medicine cannot cure epilepsy and will ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com Levetiracetam Effective, Safe in Epilepsy - Feb 5, 2007 February 5, 2007 — Levetiracetam, a new-generation antiepileptic drug, is as effective and well-tolerated as carbamazepine when used as first-line ... Medscape Levetiracetam Is Noninferior to Controlled-Release Carbamazepine in … - Sep 5, 2006 By Chris Berrie. GLASGOW, UK -- September 5, 2006 -- At optimal dosing levels and in a setting mimicking clinical practice, the novel antiepileptic drug ... DG News Pharmaceuticals get $17 million budget increase | HEALTH News - Jul 18, 2008 Crausaz says that the increase will enable it to fund a range of new medicines, such as the anti-epilepsy drug levetiracetam. ... TVNZ Fears over child epilepsy drugs - Jun 10, 2007 Professor Wong and his colleagues found three drugs in particular - lamotrigine, topiramate and levetiracetam - had seen a "massive" rise in prescribing. ... BBC News … results for new epilepsy treatment Keppra (levetiracetam) reported... - Sep 18, 2005 Data indicate that levetiracetam adjunctive therapy provides enhanced seizure ... Results show that 45% of those who received levetiracetam at a target dose ... Medical News Today - Medical News Today (press release) Levetiracetam a Promising Choice of Antiepileptic Drug in the... - Dec 9, 2005 By Fran Lowry. WASHINGTON, DC -- December 9, 2005 -- The antiepileptic drug levetiracetam appears to be particularly promising in elderly patients because ... DG News Infusion Duration of Intravenous Levetiracetam the Same for Both … - Sep 20, 2006 By Maria Bishop. BOSTON, MA -- September 20, 2006 -- Children with epilepsy aged 4 years and older will experience the predicted range of plasma ... DG News Alembic in licensing pact with Belgian co - May 24, 2007 Phase III clinical trials on Keppra XR (Levetiracetam Extended Release tablets) are ongoing and results are expected in the fourth quarter of 2007, ... Hindu Business Line US FDA grants pediatric exclusivity for UCB's Keppra(R) - Jun 6, 2008 Levetiracetam was shown to significantly reduce the frequency of partial onset seizures with 43.1% of levetiracetam-treated patients experiencing at least a ... Genetic Engineering News - Genetic Engineering News (press release) Levetiracetam (Keppra) Effective in Tough-To-Treat Patients with … - Aug 30, 2005 By Jill Stein. PARIS, FRANCE -- August 30, 2005 -- Levetiracetam (Keppra) decreases the frequency of myoclonic seizures days by 50% or more in nearly ... DG News Keppra: levetiracetam injection.(New formulations) - Oct 1, 2006 This antiepileptic is hypothesized to exert its effect by selectively preventing hypersynchronization of epileptiform burst firing and propagation of ... $4.95 - Formulary - ECNext … Filing Submitted to FDA for Keppra(R) (levetiracetam) as Treatment... - Oct 27, 2005 This application for a new indication for Keppra(R) (levetiracetam) is based on ... Keppra(R) (levetiracetam) was approved in 1999 as adjunctive therapy for ... $4.95 - PR Newswire - ECNext FDA grants pediatric exclusivity for UCB's Keppra - Jun 8, 2008 Levetiracetam was shown to significantly reduce the frequency of partial onset seizures with 43.1% of levetiracetam-treated patients experiencing at least a ... News-Medical.net Levetiracetam Effective in Combination Therapy for Some Treatment- … - Aug 29, 2007 By Chris Berrie. BRUSSELS, BELGIUM -- August 29, 2007 -- The novel antiepileptic drug (AED) levetiracetam is safe, well tolerated, and shows long-term ... DG News … Positive Opinion and FDA Approvable Letter for Keppra (levetiraceta... - Feb 3, 2006 UCB key products are Keppra (levetiracetam), Zyrtec* (cetirizine HCl), Tussionex CIII (hydrocodone polistirex/chlorpheniramine polistirex), ... Free with registration - Europe Intelligence Wire - AccessMyLibrary.com … Therapy; Binding characteristics of levetiracetam to synaptic... - Jun 14, 2006 2006 JUN 14 - (NewsRx.com) -- Scientists describe binding characteristics of levetiracetam to synaptic vesicle protein 2A (SV2A) in human brain and in CHO ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones Adjuvant levetiracetam for treating adolescent bipolar affective... - Jul 1, 2007 Case: An adolescent girl with a family history of bipolarity was brought for consultation in September 2005, presenting with delusions of grandiose identity ... Free with registration - Brown University Child and Adolescent... - AccessMyLibrary.com FDA Approves UCB's Keppra (Levetiracetam) for Use in Childhood … - Jun 24, 2005 ATLANTA, GA -- June 24, 2005 -- UCB Pharma, Inc. announced today that the US Food and Drug Administration (FDA) has approved the company's anti-epilepsy ... DG News Interim Report: UCB off to a good start in 2008 - May 15, 2008 Key products contributing to the growth in the quarter were Keppra® (levetiracetam), which continued to show double digit percentages in net sales growth as ... marketwire.com FDA Approves Keppra(R) (Levetiracetam) as Adjunctive Therapy in the … - Aug 23, 2006 BRUSSELS, BELGIUM -- August 23, 2006 -- Today UCB announced that the US Food & Drug Administration (FDA) has approved the use of Keppra® (levetiracetam) as ... DG News Antiepileptic Levetiracetam Helps Some Patients With Migraine: … - Jun 29, 2007 By Thomas S. May. STOCKHOLM, SWEDEN -- June 29, 2007 -- The new antiepileptic drug levetiracetam can help prevent migraine attacks in some patients, ... DG News Keppra XR(TM) Offers Convenient Dosing For People With Partial Onset ... - Nov 5, 2008 Keppra XR(TM) is the only extended-release formulation of levetiracetam, ... The immediate release tablet form of Keppra(R) (levetiracetam) was first ... International Business Times … Filing Submitted to FDA for Keppra(R) (levetiracetam) as Treatment... - Oct 27, 2005 Regulatory Filing Submitted to FDA for Keppra(R) (levetiracetam) as Treatment for Myoclonic Seizures. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research … Mylan Settles Its First-to-File Opportunity on Levetiracetam with... - Oct 4, 2007 Mylan Settles Its First-to-File Opportunity on Levetiracetam with UCB. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research Levetiracetam.(News from the FDA)(licensing, certification and … - Oct 1, 2006 Levetiracetam (Keppra) was approved for a new indication as adjunctive therapy in the treatment of myoclonic seizures in adults and adolescents 12 years of ... Free with registration - Patient Care for the Nurse Practitioner - AccessMyLibrary.com FDA Approvals: Tygacil, Keppra, Enbrel - Jun 30, 2005 On June 21, the FDA approved a pediatric indication for levetiracetam (Keppra ... Study results showed that levetiracetam therapy decreased mean weekly ... Medscape Levetiracetam as Add-On Therapy in Treatment-Resistant Generalised … - Jun 20, 2007 By Thomas S. May. RHODES, GREECE -- June 20, 2007 -- Levetiracetam, a novel antiepileptic drug (AED) appears to be safe and effective as add-on therapy in a ... DG News International Approvals: Keppra, Menactra, Aromasin - May 22, 2006 Levetiracetam therapy is linked to a risk for central nervous system adverse events (eg, somnolence/fatigue and behavioral abnormalities) and hematological ... Medscape FDA grants priority review to levetiracetam for use in childhood... - Feb 18, 2005 UCB Pharma Inc has been granted a priority review for the supplemental new drug application (sNDA) seeking approval of its leading anti-epilepsy drug (AED) ... Medical News Today - Medical News Today (press release) Press Release: Mylan Receives Final Approval for First-to-File... - Nov 4, 2008 In addition, after our very strong performance in the third quarter, the launch of Levetiracetam is another significant step toward the continued execution ... Pay-Per-View - PR Newswire - HighBeam Research Levetiracetam offers hope for epilepsy - Feb 9, 2007 Around a third of patients with epilepsy do not achieve sufficient control of their seizures through existing treatments, so there is a need for new ... HealthandAge.com … Hospital of Pittsburgh Study Shows Antiepileptic Drug Levetiracetam... - Apr 14, 2005 ..."Our findings suggest that levetiracetam can be an effective and well-tolerated agent for ... Levetiracetam is currently approved by the U.S. Food and Drug ... Pay-Per-View - PR Newswire - HighBeam Research Key Approval for Keppra Offers New Treatment Option for Newly … - Aug 18, 2006 Ben-Menachem E, Brodie MJ, Perucca E. Efficacy of levetiracetam monotherapy; randomized double-blind head-to-head comparison with carbamazepine-CR in newly ... Free with registration - Europe Intelligence Wire - AccessMyLibrary.com Press Release: New Keppra XR(TM) Data Highlight Its Role for Patients... - Dec 9, 2008 Safety Profile of Levetiracetam Extended Release Compared to Immediate ... Drug Application (NDA) for the use of Keppra XR(TM) (levetiracetam) in the ... Pay-Per-View - PR Newswire - HighBeam Research levetiracetam UCB supplemental filing, USA (epilepsy).(Brief Article) - Jan 10, 2005 UCB also filed an NDA for an intravenous form of levetiracetam for use as an ... levetiracetam, levetiracetam, etiracetam, (S), UCB L059 (S), SIB S1 (S), ... Pay-Per-View - R & D Focus Drug News - Factiva, from Dow Jones UCB: IV Keppra Gets EU Regulatory Nod - Apr 27, 2006 With the European Commission's approval of an intravenous (IV) formulation of Keppra (levetiracetam) for use as adjunctive therapy in the treatment of ... RedOrbit The FDA has approved UCB's anti-epileptic drug Keppra (levetiracetam).... - May 1, 2007 The FDA has approved UCB's anti-epileptic drug Keppra (levetiracetam), as adjunctive therapy in the treatment of primary generalized tonic-clonic seizures ... Free with registration - Medical Marketing & Media - AccessMyLibrary.com Epilepsy; Levetiracetam improved seizure control in patients with... - Mar 1, 2005 2005 MAR 1 - (NewsRx.com & NewsRx.net) -- Researchers have investigated levetiracetam for people with mental retardation and refractory epilepsy. ... Pay-Per-View - Science Letter - Factiva, from Dow Jones (Euronext Brussels) - UCB receives positive opinion for the use of... - Mar 7, 2006 In Europe, Keppra® (levetiracetam) is indicated as adjunctive therapy in the treatment of partial onset seizures with or without secondary generalisation in ... euronext.com For Patients With Partial-Onset Seizures - New Keppra XR Data... - Dec 10, 2008 UCB has announced findings from new studies of the once-daily antiepileptic drug (AED) Keppra XRâ„¢ (levetiracetam) extended-release tablets comparing ... Medical News Today - Medical News Today (press release) A Key Regulatory Milestone for Keppra(R) - Jul 3, 2006 In Europe, Keppra(R) (levetiracetam) is indicated as adjunctive therapy in the treatment of partial onset seizures with or without secondary generalisation ... Genetic Engineering News - Genetic Engineering News (press release) Epilepsy; Levetiracetam improved seizure control in patients with... - Mar 5, 2005 2005 MAR 5 - (NewsRx.com & NewsRx.net) -- Researchers have investigated levetiracetam for people with mental retardation and refractory epilepsy. ... Pay-Per-View - Obesity, Fitness & Wellness Week - Factiva, from Dow Jones … anti-epileptic drug Keppra (levetiracetam).(PRODUCT NEWS) |... - May 1, 2007 The FDA has approved UCB's anti-epileptic drug Keppra (levetiracetam).(PRODUCT NEWS) ... find Medical Marketing & Media articles. The FDA has approved UCB's ... Pay-Per-View - Medical Marketing & Media - HighBeam Research New Data on the Use of Keppra® (levetiracetam) as Adjunctive Treatment... - Dec 6, 2005 ...(levetiracetam) was administered as an add-on treatment during a 20 ... (levetiracetam) as adjunctive treatment in adult and paediatric ... Pay-Per-View - Hugin Press Release - Factiva, from Dow Jones Growing Demand from Epilepsy Patients for Seizure Response Dogs … - Nov 1, 2005 In the US, Keppra(R) (levetiracetam) is approved for adjunctive therapy in the treatment of partial onset seizures in adults and children 4 years of age and ... Free with registration - PR Newswire - AccessMyLibrary.com Can antiepileptic drugs unmask a susceptibility to psychiatric... - Nov 18, 2008 These agents include barbiturates, topiramate, levetiracetam and zonisamide. ... Likewise, in 517 consecutive patients treated with levetiracetam, ... Nature.com Research ids neurological disease gene - Jun 6, 2005 The binding site for current leading anti-epileptic drug Keppra (levetiracetam) has been isolated in the brain, specifically as a synaptic vesicle protein ... DrugResearcher.com … pioglitazone, but rejects levetiracetam.(Scottish Medicines... - Sep 15, 2007 The epilepsy treatment levetiracetam was refused for a range of indications (Keppra, UCB Pharma). http://www.scottishmedicines.org.uk ... $4.95 - Chemist & Druggist - ECNext … positive opinion and FDA approvable letter for Keppra (levetiraceta... - Feb 3, 2006 ...the European Medicines Agency (EMEA) has issued a positive opinion to approve marketing authorisation of Keppra (levetiracetam) Concentrate (100 mg/mL) ... Pay-Per-View - Company Reports - Factiva, from Dow Jones Clinical Trials; Anti-epileptic levetiracetam drug meets primary end... - Oct 28, 2005 2005 OCT 28 - (NewsRx.com) -- UCB Pharma announced that the primary end point from its pivotal phase 3 monotherapy clinical trial had been met. ... Pay-Per-View - Drug Week - Factiva, from Dow Jones Clinical Trials; Anti-epileptic levetiracetam drug meets primary end... - Oct 24, 2005 2005 OCT 24 - (NewsRx.com) -- UCB Pharma announced that the primary end point from its pivotal phase 3 monotherapy clinical trial had been met. ... Pay-Per-View - Health & Medicine Week - Factiva, from Dow Jones Product news from the 08/29/06 News Brief - Aug 29, 2006 The FDA has approved the use of UCB's Keppra (levetiracetam) as adjunctive therapy in the treatment of myoclonic seizures in adults and adolescents 12 years ... Medical Marketing & Media - Medical Marketing and Media Press Release: European Commission Approves Use of Anti-Epileptic … - Sep 22, 2005 Results show that 45% of those who received levetiracetam at a target dose of ... Prior to treatment with levetiracetam, the children enrolled in the study ... Pay-Per-View - PR Newswire Europe - HighBeam Research Keppra Approved for Additional Indication - Mar 27, 2007 The FDA has approved an additional indication for UCB Pharma's Keppra (levetiracetam) tablets and oral solution. The new indication provides for the use of ... Facts and Comparisons UCB hikes R&D budget nearly 60%.(Brief Article) - Jan 3, 2005 ...maximizing the potential for its anti-epilepsy drug Keppra (levetiracetam) with further indications and the development of its successors, and progress ... Free with registration - Pharma Marketletter - AccessMyLibrary.com UCB's Anti-Epileptic Keppra(R) Meets Primary End-Point in Monotherapy... - Sep 15, 2005 This trial compared Keppra(R) (levetiracetam) to sustained release ... In the US, Keppra(R) (levetiracetam) is indicated as adjunctive therapy in the ... $4.95 - PR Newswire - ECNext Epilepsy; Keppra Pregnancy Registry launched to monitor drug's impact... - Jan 3, 2005 The Keppra (levetiracetam) Pregnancy Registry is a prospective, observational, exposure-registration and follow-up study of women exposed to Keppra during ... Pay-Per-View - Pain & Central Nervous System Week - Factiva, from Dow Jones Business Update; US FDA approves Keppra Intravenous Formulation - Sep 1, 2006 2006 SEP 1 - (NewsRx.com) -- UCB announced that the US Food and Drug Administration (FDA) has approved Keppra (levetiracetam) injection 500mg/5mL (100mg/mL) ... Pay-Per-View - Drug Week - Factiva, from Dow Jones Epilepsy; Keppra Pregnancy Registry launched to monitor drug's impact... - Jan 4, 2005 The Keppra (levetiracetam) Pregnancy Registry is a prospective, observational, exposure-registration and follow-up study of women exposed to Keppra during ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones Epilepsy; Keppra Pregnancy Registry launched to monitor drug's impact... - Jan 7, 2005 The Keppra (levetiracetam) Pregnancy Registry is a prospective, observational, exposure-registration and follow-up study of women exposed to Keppra during ... Pay-Per-View - Drug Week - Factiva, from Dow Jones Keppra XR(TM) Extended-Release Tablets Filed with the FDA - Jan 15, 2008 In the extended-release levetiracetam group 10.1% of patients had 100% reduction ... The study also found that extended-release levetiracetam tablets were ... Genetic Engineering News - Genetic Engineering News (press release) Juvenile Myoclonic Epilepsy; US FDA approves Keppra as adjunctive … - Sep 18, 2006 2006 SEP 18 - (NewsRx.com) -- UCB announced that the US Food & Drug Administration (FDA) has approved the use of Keppra (levetiracetam) as adjunctive ... Pay-Per-View - Health & Medicine Week - Factiva, from Dow Jones Keppra IV formulation approved.(PRODUCTS)(Brief article) - Oct 1, 2006 The Food and Drug Administration has approved levetiracetam injection 500 mg/5 mL for use as adjunctive therapy in the treatment of partial-onset seizures ... $4.95 - Internal Medicine News - ECNext UCB's Keppra available to new epilepsy patients.(usage of Keppra)(Brie... - Sep 4, 2006 Belgian drug developer UCB says that its drug Keppra (levetiracetam) in now available in Europe to newly-diagnosed epilepsy patients. ... $4.95 - Pharma Marketletter - ECNext UCB's 1st-half profits fall 39% on Schwarz buy. - Aug 6, 2007 Key products included: the anti-epileptic Keppra (levetiracetam), sales of which grew 36% to 498.0 million euros; the prescription anti-histamine Xyzal ... $9.94 - Pharma Marketletter - Alacra Store International Approvals: Keppra, NeoRecormon, Wellbutrin XR - Jan 19, 2007 January 19, 2007 — The European Commission has approved levetiracetam for ... Patients randomized to receive levetiracetam were uptitrated for 4 weeks to a ... Medscape Press Release: US FDA Grants Pediatric Exclusivity for UCB's Keppra(R)... - Jun 6, 2008 Levetiracetam was shown to significantly reduce the frequency of partial onset seizures with 43.1% of levetiracetam-treated patients experiencing at least a ... Pay-Per-View - PR Newswire - HighBeam Research FDA Safety Changes: Keppra, Naropin, Rebetol - Dec 22, 2006 On August 15, the FDA approved safety label changes for levetiracetam tablets ... Because clinical trials of levetiracetam included a limited number of JME ... Medscape Press Release: Keppra XR(TM) Offers Convenient Dosing For People … - Nov 5, 2008 Keppra XR(TM) is the only extended-release formulation of levetiracetam, ... Application (NDA) for the use of Keppra XR(TM) (levetiracetam) in the ... Pay-Per-View - PR Newswire - HighBeam Research Keppra.(New & Approved) | Article from Pediatric News | HighBeam … - Aug 1, 2005 Keppra.(New & Approved) ... find Pediatric News articles. (levetiracetam, UCB Pharma) The Food and Drug Administration approved a new pediatric indication . Pay-Per-View - Pediatric News - HighBeam Research Article: Altabax, Keppra. - Pediatric News | HighBeam Research - FREE... - May 1, 2007 Keppra (levetiracetam, UCB Inc ... approved a new indication for Keppra ... Administration (FDA) has approved Keppra XR(TM) (levetiracetam extended ... ... Pay-Per-View - Pediatric News - HighBeam Research Article: Keppra, Tag-It Cystic Fibrosis Kit.(New & Approved) - Family... - Sep 1, 2005 New & Approved) ... find Family Practice News articles. Keppra (levetiracetam, UCB Pharma) The Food and Drug Administration approved a new ped... Pay-Per-View - Family Practice News - HighBeam Research Levetiracetam nell'epilessia generalizzata - Nov 3, 2008 Levetiracetam è un trattamento aggiuntivo ben tollerato ed efficace nel controllare le convulsioni miocloniche e tutti i tipi di convulsioni in pazienti con ... Pillole.org No More Seizures? New Drug Holds Promise for Epilepsy Patients - Jan 30, 2007 While levetiracetam is currently used as an add-on therapy by epilepsy patients, ... The study found 73 percent of people taking levetiracetam and 72.8 ... newswise.com FDA Safety Labeling Changes: Camptosar, Keppra, Prempro/Premphase - Sep 21, 2005 On June 21, the FDA approved revisions to the safety labeling for levetiracetam (Keppra tablets and oral solution, made by UCB Pharma, Inc.) to warn of the ... Medscape International Approvals: Tarceva, Cipralex, Keppra - Sep 26, 2005 Levetiracetam monotherapy has also been associated with somnolence, fatigue, ... Levetiracetam was previously approved by the FDA and the EC for the ... Medscape UCB behoudt patent voor Keppra in VS - Jun 6, 2008 Volgens de bepalingen van de overeenkomst met Mylan, en afhankelijk van goedkeuring door de FDA, zal Mylan de generische tabletten levetiracetam vanaf 1 ... Trends-Tendances - Trends-Tendances Levetiracetam, come terapia aggiuntiva, nell'epilessia idiopatica … - Feb 15, 2008 Venerdì 15 Febbraio 2008 - E'stato condotto uno studio clinico per valutare l'efficacia e la tollerabilità dell'aggiunta di Levetiracetam ( Keppra ) nei ... XagenaSalute Press Release: UCB's Anti-Epileptic Keppra(R) Meets Primary End-Point... - Sep 15, 2005 This trial compared Keppra(R) (levetiracetam) to sustained release carbamazepine in newly ... UCB Pharma, which markets the newer AED, KEPPRA (levetiracetam ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: Video: Keppra XR(TM) Approved in the US - PR … - Sep 15, 2008 Application (NDA) for the use of Keppra XR(TM) (levetiracetam) in the adjunctive ... Application (NDA) for the use of Keppra XR(TM) (levetiracetam) extended ... Pay-Per-View - PR Newswire - HighBeam Research UCB завершила III фазу клиничеÑ?кого иÑ?пытаниÑ? антиÑ?пилептичеÑ?к? - Dec 4, 2007 Также у 24% пациентов в levetiracetam – группе отмечалоÑ?ÑŒ 75 – 100-процентное Ñ?нижение чаÑ?тоты приÑ?тупов в Ñ?равнении Ñ? 11,4% пациентов в плацебо – группе. ... ФармацевтичеÑ?кий веÑ?тник EU: Levetiracetam approvato nell'epilessia mioclonica giovanile - Jun 29, 2006 Giovedì 29 Giugno 2006 - La Commissione Europea ha approvato una nuova indicazione per Levetiracetam ( Keppra ): terapia aggiuntiva nel trattamento ... XagenaSalute … administración intravenosa de Keppra® (levetiracetam) recibe la... - Feb 8, 2006 UCB anunció el pasado 3 de febrero, que el Comité de Medicamentos de Uso Humano (Committee for Medicinal Products for Human Use- CHMP) de la Agencia Europea ... acceso.com Lanzamiento del nuevo Keppra (levetiracetam) intravenoso - Jun 13, 2007 El fármaco antiepiléptico Keppra (levetiracetam) está ahora disponible en formulación intravenosa de solución para infusión. Keppra intravenoso es una ... doyma.es La FDA aprueba levetiracetam para la epilepsia infantil - Jul 15, 2005 La FDA norteamericana ha aprobado el levetiracetam, comercializado por el grupo UCB como Keppra, como terapia añadida en el tratamiento de crisis ... doyma.es Euronext - Van genoteerde ondernemingen > Persberichten - Sep 15, 2008 Keppra® (levetiracetam) in de vorm van tabletten met onmiddellijke afgifte werd voor het eerst in 1999 door de FDA goedgekeurd als adjunctieve therapie bij ... euronext.com UCB says US FDA accepts NDA filing for Keppra XR in partial onset … - Jan 16, 2008 BRUSSELS (Thomson Financial) - UCB SA said a new drug application (NDA) for the use of its Keppra XR (levetiracetam) extended-release tablets in the ... Forbes International Approvals: Foster, Keppra, ATryn - Sep 25, 2006 The European Union has approved a new indication for levetiracetam, allowing its ... Also, 55.6% of patients in the levetiracetam group vs 58.5% of those ... Medscape Studies show Keppra® reduces seizure frequency in patients with brain... - Apr 25, 2005 Keppra® ( levetiracetam ) is indicated as adjunctive therapy in the treatment of partial ... Levetiracetam Use in Brain Tumor Patients. Abstract P01.066. ... i-newswire.com |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |